SC
GDRX icon

Solstein Capital’s GoodRx Holdings GDRX Stock Holding History

Solstein Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$2K – 480
2021
Q2 		$2K Sell
50
-4,635
-99% -$171K ﹤0.01% 415
2021
Q1 		$183K Buy
+4,685
New +$211K 0.25% 107

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Solstein Capital's GDRX Position: Q3 2021 in Review

Solstein Capital sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 50 shares — an estimated $2K sold.

Solstein Capital first reported a position in GDRX in Q1 2021 and held it in 2 quarters. The position peaked at $183K in Q1 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

  • Solstein Capital reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
  • Solstein Capital sold 50 GoodRx Holdings shares in Q3 2021, an estimated $2K.
  • Solstein Capital first reported a position in GoodRx Holdings in Q1 2021 and held it in 2 quarters.
  • Solstein Capital's GoodRx Holdings position peaked at $183K in Q1 2021.
  • 218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Solstein Capital's 13F filing for Q3 2021, filed 27 Oct 2021.